登录

首页 > 资讯动态

FDA批准Voxelotor治疗镰状细胞病 2019.11.25

FDA approves voxelotor for sickle cell disease On November 25, 2019, the Food and Drug Administration granted accelerated approval to voxelotor (Oxbryta, Global Blood Therapeutics) for adults and pediatric patients 12 years of age and older with si...